Skip to Content
Merck
  • Palisade Endings of Extraocular Muscles Develop Postnatally Following Different Time Courses.

Palisade Endings of Extraocular Muscles Develop Postnatally Following Different Time Courses.

Investigative ophthalmology & visual science (2017-10-08)
Roland Blumer, Johannes Streicher, María A Davis-López de Carrizosa, Rosa R de la Cruz, Angel M Pastor
ABSTRACT

To analyze in a frontal-eyed mammal (cat) the postnatal development of palisade endings in extraocular muscles (EOMs) and to compare the spatiotemporal and quantitative patterns of palisade endings among individual rectus muscles. Cats of different ages ranging from birth to adult stage were studied. EOM whole-mount preparations were fluorescently labeled using six combinations of triple staining and analyzed in the confocal laser scanning microscope. Palisade endings developed postnatally and passed in each rectus muscle through the same, three developmental steps but in a heterochronic sequence and to a different final density per muscle. Specifically, palisade ending development was first completed in the medial rectus and later in the inferior, lateral, and superior rectus. The highest density of palisade endings was observed in the medial rectus and the lowest in the lateral rectus whereas values for the inferior and superior rectus were in between. Palisade endings expressed high levels of growth associated protein 43 during development and were supplied by axons that established motor terminals. Cats open their eyes 7 to 10 days after birth and later develop a complex three-dimensional visuomotor climbing and jumping behavior depending on accurate binocular vision and fine tuning of the ocular movements. Our findings indicate that palisade ending development correlates with important landmarks in visuomotor behavior and provide support for our previous notion that palisade endings play an important role for convergence eye movements in frontal-eyed species.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phalloidin–Atto 647N, BioReagent, suitable for fluorescence, ≥80% (HPLC)
Sigma-Aldrich
Anti-Growth Associated Protein 43 Antibody, serum, Chemicon®
Sigma-Aldrich
Anti-Neurofilament H Antibody, Chemicon®, from chicken
Sigma-Aldrich
Anti-Choline Acetyltransferase Antibody, Chemicon®, from goat
Sigma-Aldrich
Anti-Synaptophysin Antibody, clone SP15, ascites fluid, clone SP15, Chemicon®